Table 3.

Summary of Treatment Effects in Group A and B

Values are mean±standard deviation

Group A: patients injected with 0.5% lidocaine 5 ml+triamcinolone 40 mg+high molecular weight sodium hyaluronate 2 ml, Group B: patients injected with 0.5% lidocaine+triamcinolone 40 mg, VAS: Visual analogue scale, SFA: Shoulder function assessment scale, SDQ: Shoulder disability questionnaire

^*p<0.05 pre-injection vs 2 weeks after 3^rd injection, ^†p<0.05 pre-injection vs 1 week after 1^st injection, ^‡p<0.05 1 week after 1^st injection vs 1 week after 2^nd injection, ^§p<0.05 1 week after 2^nd injection vs 2 week after 3^rd injection